The user facility reported that during a patient procedure, their fastflo sclerotherapy needle was "dull, tearing the tissue".There was no additional medical intervention required.The procedure was completed successfully using a different needle.
Additional Manufacturer Narrative
Investigation of the reported event is in process.A follow-up report will be submitted once additional information becomes available.